STOCK TITAN

Director at Timken (NYSE: TKR) granted 2,270 vested shares

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Timken Company director Christopher L. Mapes acquired 2,270 shares of Common Stock as a stock award. The shares were issued at no cash cost to him in connection with the vesting of 100% of time-based restricted share units granted on May 2, 2025. Following this vesting, he directly holds 30,585 Timken shares, reflecting routine equity compensation rather than an open-market purchase or sale.

Positive

  • None.

Negative

  • None.
Insider MAPES CHRISTOPHER L
Role null
Type Security Shares Price Value
Grant/Award Common Stock 2,270 $0.00 --
Holdings After Transaction: Common Stock — 30,585 shares (Direct, null)
Footnotes (1)
  1. [object Object]
Shares acquired via award 2,270 shares Common Stock granted as time-based RSUs vesting on May 2, 2026
Price per share for award $0.00 per share Equity award, not an open-market purchase
Shares held after transaction 30,585 shares Total direct Timken holdings for Christopher L. Mapes after vesting
Transactions acquiring shares 1 transaction Form 4 summary shows one acquire-type award
time-based restricted share units financial
"Represents vesting of 100% of the time-based restricted share units granted on May 2, 2025."
Form 4 regulatory
"INSIDER FILING DATA (Form 4):"
Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.
Grant, award, or other acquisition financial
"transaction_code_description": "Grant, award, or other acquisition""
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
MAPES CHRISTOPHER L

(Last)(First)(Middle)
4500 MT. PLEASANT ST. NW

(Street)
NORTH CANTON OHIO 44720

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
TIMKEN CO [ TKR ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
05/02/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock(1)05/02/2026A2,270A$030,585D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. Represents vesting of 100% of the time-based restricted share units granted on May 2, 2025.
Remarks:
/s/ Christopher L. Mapes05/04/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did Timken (TKR) director Christopher Mapes report in this Form 4?

Christopher L. Mapes reported acquiring 2,270 Timken Common Stock shares as an equity award. The shares resulted from vesting of previously granted time-based restricted share units and involved no cash purchase in the open market, reflecting routine director compensation.

How many Timken (TKR) shares does Christopher Mapes hold after this transaction?

After the reported transaction, Christopher L. Mapes directly holds 30,585 Timken Common Stock shares. This total includes the 2,270 shares acquired through the vesting of time-based restricted share units granted on May 2, 2025 under the company’s equity compensation arrangements.

Was the Timken (TKR) Form 4 transaction an open-market buy or sell?

The Form 4 transaction was not an open-market buy or sell. It reflects a grant or award acquisition, where 2,270 shares were issued at no price upon vesting of time-based restricted share units granted on May 2, 2025 to director Christopher L. Mapes.

What is the origin of the 2,270 Timken (TKR) shares reported in the filing?

The 2,270 shares come from vesting of time-based restricted share units. According to the footnote, they represent 100% of the restricted share units granted on May 2, 2025, which converted into Timken Common Stock for director Christopher L. Mapes at no cash exercise price.

Does the Timken (TKR) Form 4 indicate any derivative securities remaining for Christopher Mapes?

The Form 4 summary shows no remaining derivative securities for Christopher L. Mapes. The derivativeSummary section is empty, indicating the reported activity involves only non-derivative Common Stock resulting from vested time-based restricted share units, with no listed options or similar instruments.